Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma

Leukemia Research

Volumn 33, Issue 9, 2009, Pages

  Seker, Mesut ^a   Bilici, Ahmet ^a   Ustaalioglu, Basak Oven ^a   Salman, Tarik ^a   Sonmez, Berkant ^a   Canpolat, Nesrin A ^b   Salepci, Taflan ^a   Gumus, Mahmut ^a   Yaylaci, Mustafa ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Department of Cardiovascular Surgery Anesthesiology and Reanimation   (Turkey)

Author keywords

MALT lymphoma; Rituximab

Indexed keywords

ANTIBIOTIC AGENT; CD20 ANTIGEN; CD79A ANTIGEN; HEMOGLOBIN A1C; LACTATE DEHYDROGENASE; LEUKOSIALIN; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ANEMIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG DOSE REGIMEN; DYSPNEA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG BIOPSY; LUNG TUMOR; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE CYCLE TREATMENT; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 67549104895     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.026     Document Type: Letter

References (17)

1. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., and Gatter K.C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 5 (1994) 1361-1392
2. Issacson P., and Wright D.H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52 (1983) 1410-1416
3. Zinzani P.L., Magagnoli M., Galieni P., Martelli M., Poletti V., and Zaja F. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 17 (1999) 1254-1258
4. Miller D.L., and Allen M.S. Rare pulmonary neoplasm. Mayo Clin Proc 68 (1993) 492-498
5. Ahmed S., Siddiqui A.K., and Rai K.R. Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma. Cancer Invest 20 (2002) 1059-1068
6. Sminia T., and van der Brugge-Gamelkoorn G.J. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol 9 (1989) 119-150
7. Issacson P.G. Mucosa-associated lymphoid tissue lymphoma. Semin Haematol 36 (1999) 139-147
8. Tsang R.W., Gospodarowicz M.K., Pintilie M., Bezjak A., Wells W., Hodgson D.C., and Crump M. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 50 5 (2001) 1258-1264
9. Chong E.A., Svoboda J., Cherian S., Andreadis C., Downs L.H., Zhuang H., Alavi A., Tsai D.E., and Schuster S.J. Regression of pulmonary MALT lymphoma after treatment with rituximab. Leuk Lymphoma 46 9 (2005) 1383-1386
10. Ahmed S., Kussick S.J., Siddiqui A.K., Bhuiya T.A., Khan A., Sarewitz S., Steinberg H., Sison C.P., and Rai K.R. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 40 9 (2004) 1320-1326
11. Stefanovic A., Morgensztern D., Fong T., and Lossos I.S. Pulmonary marginal-zone lymphoma: a single centre experience and review of the SEER database. Leuk Lymphoma 49 7 (2008) 1311-1320
12. Arkenau H.T., Gordon C., Cunningham D., Norman A., Wotherspoon A., and Chau I. Mucosa-associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma 48 3 (2007) 547-550
13. Ferraro P., Trastek V.F., Adlakha H., Deschamps C., Allen M.S., and Pairolero P.C. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 69 4 (2000) 993-997
14. Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31 (2005) 456-473
15. Czuczman M.S., Grillo-López A.J., White C.A., Saleh M., Gordon L., LoBuglio A.F., Jonas C., Klippenstein D., Dallaire B., and Varns C. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17 1 (1999) 268-276
16. Piro L.D., White C.A., Grillo-López A.J., Janakiraman N., Saven A., and Beck T.M. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 10 (1999) 655-661
17. Salepci T., Seker M., Kurnaz E., Guler D.O., Bilici A., Dane F., Aliustaoglu M., Atesoglu E.B., Gumus M., and Yaylaci M. Conjunctival malt lymphoma successfully treated with single agent rituximab therapy. Leuk Res 33 3 (2009) e10-e13